Alkaline lipolytic enzyme

Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Hydrolase

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S195000, C435S252300, C435S320100, C536S023200, C536S023740, C530S350000, C510S226000

Reexamination Certificate

active

06350604

ABSTRACT:

TECHNICAL FIELD
This invention relates to an alkaline lipolytic enzyme, a detergent composition comprising the enzyme, methods of producing the enzyme, an isolated DNA sequence encoding the enzyme, a recombinant expression vector comprising the DNA sequence and cells comprising the DNA sequence or the vector.
BACKGROUND ART
For a number of years lipolytic enzymes have been used as detergent additives to remove lipid or fatty stains.
Thus, the prior art suggests the use of various lipolytic enzymes with lipase or cutinase activity as detergent additives. Examples include microbial lipolytic enzymes derived from strains of Fusarium, e.g.
F. oxysporum
(EP 130 064) and
F. solani f.
sp.
pisi
(WO 90/09446),
Humicola lanuginosa
(also called
Thermomyces lanuginosus,
EP 258 068 and EP 305 216), Pseudomonas, e.g.
P. alcaligenes
and
P. pseudoalcaligenes
(EP 218 272),
P. cepacia
(EP 331 376),
P. mendocina
(WO 88/09367), and Bacillus, e.g.
B. subtilis
(Dartois et al., (1993) Biochemica et Biophysica acta 1131, 253-260),
B. stearothermophilus
(JP 64/74992) and
B. pumilus
(WO 91/16422).
It is the object of this invention to provide lipolytic enzymes having good washing performance and stability in a detergent solution.
STATEMENT OF THE INVENTION
Surprisingly, we have found that alkaline lipolytic enzymes can be obtained from filamentous fungi of the genera Gliocladium, Verticillium and Trichophaea and that the lipolytic enzymes are effective for improving the effect of detergents. The lipolytic enzymes have a good washing performance and stability in a detergent solution.
Full length cDNA sequences each encoding a lipolytic enzyme according to the invention were derived from three strains of Giiocladium sp., Verticillium sp. and
Trichophaea saccata
as donor organisms. The cDNA sequences were cloned into the plasmid pYES 2.0 present in
Escherichia coli.,
and the cloned
E. coli
strains were deposited by the inventors, as shown in the table below. The lipolytic enzyme encoding DNA sequence harbored in the deposited
E. coli
strain is believed to have the sequence shown in the positions and listing indicated below, and the amino acid sequence deduced therefrom is shown in the indicated positions and listing.
The information is summarized below:
Donor organism
Gliocladium sp.
Verticillium sp.
T. saccata
Donor strain
CBS 173.96
CBS 830.95
CBS 804.70
E. coli transformant
DSM 10591
DSM 10590
DSM 11298
DNA sequence
SEQ ID NO: 2
SEQ ID NO: 5
SEQ ID NO: 7
listing
DNA positions
114-713
133-738
161-763
Amino acid
SEQ ID NO: 3
SEQ ID NO: 6
SEQ ID NO: 8
sequence listing
Amino acid
 1-200
 1-202
 1-201
positions
Homologies of the above DNA and amino acid sequences were calculated by methods described later in this specification. The following homologies were found between pairs of sequences, amino acid homology at the upper right corner, and DNA homology at the lower left. (given as DNA homology/amino acid homology):
Gliocladium sp.
Verticillium sp.
T. saccata
Gliocladium sp.
100 
91
96
Verticillium sp.
83
100 
89
T. saccata
92
83
100 
Accordingly, the invention in its various aspects provides:
1. A lipolytic enzyme which is:
a) a polypeptide encoded by the lipolytic enzyme encoding part of the DNA sequence cloned into a plasmid present in
Escherichia coli
DSM 10591, DSM 10590 or DSM 11298, or
b) a polypeptide produced by Gliocladium sp. CBS 173.96, Verticillium sp. CBS 830.95 or
Trichophaea saccata
CBS 804.70, or
c) a polypeptide having an amino acid sequence as shown in positions 1-200 of SEQ ID NO: 3, positions 1-202 of SEQ ID NO: 6, or positions 1-201 of SEQ ID NO: 8, or
d) an analogue of the polypeptide defined in (a), (b) or (c) which:
i) is at least 60% homologous with said polypeptide, or
ii) is immunologically reactive with an antibody raised against said polypeptide in purified form.
2. An alkaline lipolytic enzyme which is derivable from a strain of Gliocladium and has a lipolytic activity at pH 10 in the absence of Ca
++
above 20% of the lipolytic activity at pH 10 in the presence of 50 mM Ca
++
.
3. An alkaline lipolytic enzyme which is derivable from a strain of Gliocladium and gives a degree of hydrolysis above 15% on cotton/olive oil swatches in the Activity-in-Detergent (AiD) assay.
4. An alkaline lipolytic enzyme which is derivable from a strain of the genus Verticillium and retains more than 90% activity after 30 minutes incubation at pH 10.2, 40° C. in a solution of 0.300 g/l C
14
-C
16
alkyl sulfate, 0.650 g/l alcohol ethoxylate (C
12
-C
14
, 6 EO), 1.750 zeolite P, 0.145 g/l Na
2
CO
3
, 0.020 g/l acrylate/maleate copolymer and 0.050 g/l carboxymethyl cellulose.
5. An enzymatic detergent composition comprising a surfactant and the lipolytic enzyme of any preceding claim.
6. A method of producing an alkaline lipolytic enzyme, comprising cultivation of a lipolytic enzyme-producing strain of Gliocladium, Verticillium or Trichophaea in a suitable nutrient medium, followed by recovery of the alkaline lipolytic enzyme.
7. A method for producing an alkaline lipolytic enzyme, comprising:
a) isolating a DNA sequence encoding the lipolytic enzyme from a lipolytic enzyme-producing strain of Gliocladium, Verticillium or Trichophaea,
b) combining the DNA fragment with appropriate expression signal(s) in an appropriate vector,
c) transforming a suitable heterologous host organism with the vector,
d) cultivating the transformed host organism under conditions leading to expression of the lipolytic enzyme, and
e) recovering the lipolytic enzyme from the culture medium.
8. An isolated DNA sequence which encodes the lipolytic enzyme of any of claims 1-7.
9. An isolated, lipolytic enzyme encoding DNA sequence which comprises:
a) the lipolytic enzyme encoding part of the DNA sequence cloned into a plasmid present in
Escherichia coli
DSM 10591, DSM 10590 or DSM 11298, or
b) the DNA sequence shown in positions 114-713 of SEQ ID NO: 2, positions 133-738 of SEQ ID NO: 5 or positions 161-763 of SEQ ID NO: 7, or
c) an analogue of the DNA sequence defined in a) or b) which
i) is at least 60% homologous with said DNA sequence, or
ii) hybridizes with said DNA sequence at 55° C.
10. A recombinant expression vector comprising the DNA sequence of any of claims 19-24.
11. A cell comprising the DNA sequence of any of claims 19-24 or the recombinant expression vector of claim 25.
12. A method of producing a lipolytic enzyme, comprising culturing the cell of any of claims 26-29 under conditions permitting the production of the enzyme, and recovering the enzyme from the culture.
13. A biologically pure culture of a microbial strain which belongs to the genus Gliocladium or Verticillium and is capable of producing an alkaline lipolytic enzyme.
14.
Escherichia coli
strain DSM 10591, DSM 10590 or DSM 11298 or a mutant thereof having lipolytic enzyme encoding capability.
COMPARISON WITH PRIOR ART
Tilburg and Thomas, Application. Environ. Microbiol., January 1993, p. 236-242 describes production of lipase by
G. virens;
however, data in the article show that the prior-art lipase is not alkaline. U.S. Pat. Nos. 4,985,365 and 4,511,655 describe the use of culture broth of
G. roseum
IFO 5422 and
G. virens
IFO 6355 to hydrolyze carboxylic esters at acid pH. The prior art does not describe the production of lipolytic activity at alkaline pH by strains of Gliocladium.
The prior art describes the production of lipase by
Verticillium cinnabarinum
(also called
V. Iuteoalbum
) DSM 63078 (Rapp & Backhaus, Enzyme Microb. Technol., 14, 938-943 (1992)) and
Verticillium lecanii
ATCC 26854 (JP-A 61-289884). The inventors have investigated the two strains and found that they do not produce alkaline lipolytic enzyme.
The following literature describes lipase production by the genus Verticillium without identifying any particular strains: Kunert & Lysek, Biologica (Bratislava), 42 (3), 285-293 (1987). Leger et al., J. Invertebr. Pathol., 48, 85-95 (1986). Jackson et al., Ann. appl. Biol., 106, 39-48 (1985). Roberts et al., Mycologia, 79 (2), 265-2

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Alkaline lipolytic enzyme does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Alkaline lipolytic enzyme, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkaline lipolytic enzyme will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2973952

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.